121 related articles for article (PubMed ID: 32391002)
21. Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.
Furuichi K; Kaneko S; Wada T
Clin Exp Nephrol; 2009 Feb; 13(1):9-14. PubMed ID: 19085040
[TBL] [Abstract][Full Text] [Related]
22. Immune mechanisms and novel pharmacological therapies of acute kidney injury.
Bajwa A; Kinsey GR; Okusa MD
Curr Drug Targets; 2009 Dec; 10(12):1196-204. PubMed ID: 19715538
[TBL] [Abstract][Full Text] [Related]
23. Substance P Improves Renal Ischemia Reperfusion Injury Through Modulating Immune Response.
Kim DJ; Moon JY; Kim SM; Seo JW; Lee YH; Jung SW; Kim K; Kim YG; Lim SJ; Lee S; Son Y; Lee SH
Front Immunol; 2020; 11():600. PubMed ID: 32391002
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
25. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
Front Immunol; 2021; 12():637335. PubMed ID: 33767704
[TBL] [Abstract][Full Text] [Related]
26. Aging has small effects on initial ischemic acute kidney injury development despite changing intrarenal immunologic micromilieu in mice.
Jang HR; Park JH; Kwon GY; Park JB; Lee JE; Kim DJ; Kim YG; Kim SJ; Oh HY; Huh W
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F272-83. PubMed ID: 26661651
[TBL] [Abstract][Full Text] [Related]
27. Exosome from indoleamine 2,3-dioxygenase-overexpressing bone marrow mesenchymal stem cells accelerates repair process of ischemia/reperfusion-induced acute kidney injury by regulating macrophages polarization.
Xie X; Yang X; Wu J; Tang S; Yang L; Fei X; Wang M
Stem Cell Res Ther; 2022 Jul; 13(1):367. PubMed ID: 35902956
[TBL] [Abstract][Full Text] [Related]
28. Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL-33/ST2 to Alleviate Renal Ischemia-Reperfusion Injury.
Xu L; Xing Z; Yuan J; Han Y; Jiang Z; Han M; Hou X; Xing W; Li Z
Adv Healthc Mater; 2024 May; 13(13):e2303276. PubMed ID: 38335143
[TBL] [Abstract][Full Text] [Related]
29. Use of mesenchymal stem cells for chronic kidney disease.
Chung BH
Kidney Res Clin Pract; 2019 Jun; 38(2):131-134. PubMed ID: 31189218
[No Abstract] [Full Text] [Related]
30. M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients.
Hu W; Lin J; Lian X; Yu F; Liu W; Wu Y; Fang X; Liang X; Hao W
Clin Immunol; 2019 Aug; 205():8-15. PubMed ID: 31078708
[TBL] [Abstract][Full Text] [Related]
31. Diacerein protects against glycerol-induced acute kidney injury: Modulating oxidative stress, inflammation, apoptosis and necroptosis.
Abd-Ellatif RN; Hegab II; Atef MM; Sadek MT; Hafez YM
Chem Biol Interact; 2019 Jun; 306():47-53. PubMed ID: 30974099
[TBL] [Abstract][Full Text] [Related]
32. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
[TBL] [Abstract][Full Text] [Related]
33. Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated Inflammation.
Hong HS; Kim S; Lee S; Woo JS; Lee KH; Cheng XW; Son Y; Kim W
Cell Physiol Biochem; 2019; 52(1):40-56. PubMed ID: 30790504
[TBL] [Abstract][Full Text] [Related]
34. Substance P and thiorphan synergically enhance angiogenesis in wound healing.
Um J; Yu J; Dubon MJ; Park KS
Tissue Eng Regen Med; 2016 Apr; 13(2):149-154. PubMed ID: 30603394
[TBL] [Abstract][Full Text] [Related]
35. In Situ Blood Vessel Regeneration Using SP (Substance P) and SDF (Stromal Cell-Derived Factor)-1α Peptide Eluting Vascular Grafts.
Shafiq M; Zhang Q; Zhi D; Wang K; Kong D; Kim DH; Kim SH
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):e117-e134. PubMed ID: 29853570
[TBL] [Abstract][Full Text] [Related]
36. Substance P ameliorates tumor necrosis factor-alpha-induced endothelial cell dysfunction by regulating eNOS expression in vitro.
Piao J; Hong HS; Son Y
Microcirculation; 2018 Apr; 25(3):e12443. PubMed ID: 29412499
[TBL] [Abstract][Full Text] [Related]
37. Macrophage plasticity, polarization, and function in health and disease.
Shapouri-Moghaddam A; Mohammadian S; Vazini H; Taghadosi M; Esmaeili SA; Mardani F; Seifi B; Mohammadi A; Afshari JT; Sahebkar A
J Cell Physiol; 2018 Sep; 233(9):6425-6440. PubMed ID: 29319160
[TBL] [Abstract][Full Text] [Related]
38. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.
Yoo K; Son BK; Kim S; Son Y; Yu SY; Hong HS
Mol Vis; 2017; 23():933-943. PubMed ID: 29296073
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
